| Year |
Citation |
Score |
| 2020 |
Vaubel R, Zschernack V, Tran QT, Jenkins S, Caron A, Milosevic D, Smadbeck J, Vasmatzis G, Kandels D, Gnekow A, Kramm C, Jenkins R, Kipp BR, Rodriguez FJ, Orr BA, et al. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it? Brain Pathology (Zurich, Switzerland). PMID 32619305 DOI: 10.1111/Bpa.12874 |
0.308 |
|
| 2020 |
Polonis K, Schultz MJ, Olteanu H, Smadbeck JB, Johnson SH, Vasmatzis G, Xu X, Greipp PT, Ketterling RP, Hoppman NL, Baughn LB, Peterson JF. Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing. Annals of Diagnostic Pathology. 46: 151533. PMID 32408254 DOI: 10.1016/J.Anndiagpath.2020.151533 |
0.37 |
|
| 2020 |
Lopes JL, Webley M, Pitel BA, Pearce KE, Smadbeck JB, Johnson SH, Vasmatzis G, Sukov WR, Greipp PT, Hoppman NL, Ketterling RP, Baughn LB, Finn L, Peterson JF. Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis. Cancer Genetics. 243: 48-51. PMID 32272434 DOI: 10.1016/J.Cancergen.2020.02.008 |
0.348 |
|
| 2020 |
Mansfield AS, Peikert T, Vasmatzis G. Chromosomal rearrangements and their neoantigenic potential in mesothelioma. Translational Lung Cancer Research. 9: S92-S99. PMID 32206575 DOI: 10.21037/Tlcr.2019.11.12 |
0.417 |
|
| 2020 |
Pitel B, Fadra N, Davila J, Greipp P, Hoppman N, Jackson R, Jenkins R, Johnson S, Luoma I, Minn K, Mopuri R, Nair A, Pearce K, Peterson J, Smadbeck J, ... Vasmatzis G, et al. 42. Genomic gymnastics: Using RNAseq and mate pair sequencing to collaboratively decipher structural variation Cancer Genetics and Cytogenetics. 244: 16. DOI: 10.1016/J.Cancergen.2020.04.046 |
0.307 |
|
| 2019 |
Blackburn PR, Huang L, Dalovisio A, Pitel BA, Chen D, Oliveira JL, Wood AJ, Smadbeck JB, Johnson SH, Vasmatzis G, Haferlach C, Greipp PT, Hoppman NL, Ketterling RP, Baughn LB, et al. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion. Cancer Genetics. PMID 31902694 DOI: 10.1016/J.Cancergen.2019.12.005 |
0.315 |
|
| 2019 |
Smadbeck J, Peterson JF, Pearce KE, Pitel BA, Figueroa AL, Timm M, Jevremovic AD, Shi M, Stewart AK, Braggio E, Riggs DL, Bergsagel PL, Vasmatzis G, Kearney HM, Hoppman NL, et al. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma. Blood Cancer Journal. 9: 103. PMID 31844041 DOI: 10.1038/S41408-019-0255-Z |
0.345 |
|
| 2019 |
Schultz MJ, Blackburn PR, Cogbill CH, Pitel BA, Smadbeck JB, Johnson SH, Vasmatzis G, Rech KL, Sukov WR, Greipp PT, Hoppman NL, Baughn LB, Ketterling RP, Peterson JF. Characterization of a cryptic fusion by mate-pair sequencing in a case of acute promyelocytic leukemia with a normal karyotype and negative FISH studies. Leukemia & Lymphoma. 1-4. PMID 31809670 DOI: 10.1080/10428194.2019.1699081 |
0.316 |
|
| 2019 |
Rowsey RA, Smoley SA, Williamson CM, Vasmatzis G, Smadbeck JB, Ning Y, Greipp PT, Hoppman NL, Baughn LB, Ketterling RP, Peterson JF. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion. Blood Cancer Journal. 9: 81. PMID 31575852 DOI: 10.1038/S41408-019-0239-Z |
0.344 |
|
| 2019 |
Peterson JF, He RR, Nayer H, Cuevo RS, Smadbeck JB, Vasmatzis G, Greipp PT, Ketterling RP, Hoppman NL, Baughn LB. Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy. Cancer Genetics. 237: 51-54. PMID 31447065 DOI: 10.1016/J.Cancergen.2019.06.007 |
0.34 |
|
| 2019 |
Peterson JF, Meyer RG, Smoley SA, Webley M, Smadbeck JB, Vasmatzis G, Pearce K, Greipp PT, Ketterling RP, Craig FE, Stewart AK, Baughn LB. Whole Genome Mate-pair Sequencing of Plasma Cell Neoplasm as a Novel Diagnostic Strategy: A Case of Unrecognized t(2;11) Structural Variation. Clinical Lymphoma, Myeloma & Leukemia. PMID 31320253 DOI: 10.1016/J.Clml.2019.06.006 |
0.324 |
|
| 2019 |
Murphy SJ, Harris FR, Kosari F, Terra S, Nasir A, Johnson SH, Serla V, Smadbeck JB, Halling GC, Karagouga G, Sukov B, Leventakos K, Yang P, Peikert T, Mansfield AS, ... ... Vasmatzis G, et al. Using genomics to differentiate multiple primaries from metastatic lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31103780 DOI: 10.1016/J.Jtho.2019.05.008 |
0.349 |
|
| 2019 |
Muppa P, Parrilha Terra SB, Sharma A, Mansfield AS, Aubry MC, Bhinge K, Asiedu MK, de Andrade M, Janaki N, Murphy SJ, Nasir A, Van Keulen V, Vasmatzis G, Wigle DA, Yang P, et al. Immune Cell Infiltration May be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31078775 DOI: 10.1016/J.Jtho.2019.03.028 |
0.31 |
|
| 2019 |
Peterson JF, Baughn LB, Ketterling RP, Pitel BA, Smoley SA, Vasmatzis G, Smadbeck JB, Greipp PT, Mangaonkar AA, Thompson CA, Parikh SA, Chen D, Viswanatha DS. Characterization of a cryptic rearrangement in a case of mantle cell lymphoma with negative FISH studies. Blood Advances. 3: 1298-1302. PMID 31015206 DOI: 10.1182/Bloodadvances.2019031450 |
0.327 |
|
| 2019 |
Bryce AH, Egan JB, Smadbeck JB, Johnson SH, Murphy SJ, Harris FR, Halling GC, Terra SBSP, Cheville J, Pagliaro L, Leibovich B, Costello BA, Vasmatzis G. Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing. Scientific Reports. 9: 3586. PMID 30837548 DOI: 10.1038/S41598-019-39956-Y |
0.375 |
|
| 2019 |
Rusheen AE, Smadbeck JB, Schimmenti LA, Klee EW, Link MJ, Vasmatzis G, Carlson ML. Proposal for Modification of Cahan's Criteria Utilizing Molecular Genetic Analyses for Cases without Baseline Histopathology: A Unique Method Applicable to Primary Radiosurgery. Journal of Neurological Surgery. Part B, Skull Base. 80: 10-17. PMID 30733895 DOI: 10.1055/S-0038-1655759 |
0.357 |
|
| 2019 |
Peterson JF, Sukov WR, Pitel BA, Smoley SA, Pearce KE, Meyer RG, Williamson CM, Smadbeck JB, Vasmatzis G, Hoppman NL, Greipp PT, Baughn LB, Ketterling RP. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory. Genes, Chromosomes & Cancer. PMID 30707474 DOI: 10.1002/Gcc.22741 |
0.321 |
|
| 2019 |
Peterson JF, Smoley SA, Luoma IM, Pitel BA, Rice CS, Demasi JCB, Vasmatzis G, Smadbeck JB, Yang T, Greipp PT, Ketterling RP, Baughn LB. Characterization of a cryptic KMT2A/AFF1 gene fusion by mate-pair sequencing (MPseq) in a young adult with newly diagnosed B-lymphoblastic leukemia Journal of Hematopathology. 12: 99-104. DOI: 10.1007/S12308-019-00355-X |
0.343 |
|
| 2018 |
Harris FR, Zhang P, Yang L, Hou X, Leventakos K, Weroha SJ, Vasmatzis G, Kovtun IV. Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy. Molecular Oncology. PMID 30499260 DOI: 10.1002/1878-0261.12414 |
0.338 |
|
| 2018 |
Mansfield AS, Peikert T, Smadbeck JB, Udell JBM, Garcia-Rivera E, Elsbernd L, Erskine CL, Van Keulen VP, Kosari F, Murphy SJ, Ren H, Serla VV, Schaefer Klein JL, Karagouga G, Harris FR, ... ... Vasmatzis G, et al. Neoantigenic potential of complex chromosomal rearrangements in mesothelioma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30316012 DOI: 10.1016/J.Jtho.2018.10.001 |
0.3 |
|
| 2018 |
Aypar U, Smoley SA, Pitel BA, Pearce KE, Zenka RM, Vasmatzis G, Johnson SH, Smadbeck JB, Peterson JF, Geiersbach KB, Van Dyke DL, Thorland EC, Jenkins RB, Ketterling RP, Greipp PT, et al. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia. European Journal of Haematology. PMID 30270457 DOI: 10.1111/Ejh.13179 |
0.34 |
|
| 2018 |
Peterson JF, Pitel BA, Smoley SA, Smadbeck JB, Johnson SH, Vasmatzis G, Kearney HM, Greipp PT, Hoppman NL, Baughn LB, Ketterling RP. Use of mate-pair sequencing (MPseq) to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia. Human Pathology. PMID 30267776 DOI: 10.1016/J.Humpath.2018.09.010 |
0.333 |
|
| 2018 |
Smadbeck JB, Johnson SH, Smoley SA, Gaitatzes A, Drucker TM, Zenka RM, Kosari F, Murphy SJ, Hoppman N, Aypar U, Sukov WR, Jenkins RB, Kearney HM, Feldman AL, Vasmatzis G. Copy Number Variant Analysis using Genome-Wide Mate-Pair Sequencing. Genes, Chromosomes & Cancer. PMID 29726617 DOI: 10.1002/Gcc.5 |
0.357 |
|
| 2018 |
Rizvi S, Fischbach SR, Bronk SF, Hirsova P, Krishnan A, Dhanasekaran R, Smadbeck JB, Smoot RL, Vasmatzis G, Gores GJ. YAP-associated chromosomal instability and cholangiocarcinoma in mice. Oncotarget. 9: 5892-5905. PMID 29464042 DOI: 10.18632/Oncotarget.23638 |
0.355 |
|
| 2018 |
Johnson SH, Smadbeck JB, Smoley SA, Gaitatzes A, Murphy SJ, Harris FR, Drucker TM, Zenka RM, Pitel BA, Rowsey RA, Hoppman NL, Aypar U, Sukov WR, Jenkins RB, Feldman AL, ... ... Vasmatzis G, et al. SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq). Cancer Genetics. 221: 1-18. PMID 29405991 DOI: 10.1016/J.Cancergen.2017.11.009 |
0.354 |
|
| 2018 |
Asiedu MK, Thomas CF, Dong J, Schulte Tomaszek SC, Khadka P, Sun Z, Kosari F, Jen J, Molina JR, Vasmatzis G, Kuang R, Aubry MC, Yang P, Wigle DA. Pathways impacted by genomic alterations in pulmonary carcinoid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29351916 DOI: 10.1158/1078-0432.Ccr-17-0252 |
0.305 |
|
| 2018 |
Farooq M, Egan JB, McDonald B, Markus H, Contente-Cuomo T, Fernandez-Zapico M, Vasmatzis G, Braggio E, Borad MJ, Murtaza M. Detection of copy number aberrations in cholangiocarcinoma using shallow whole genome sequencing of plasma DNA. Journal of Clinical Oncology. 36: 293-293. DOI: 10.1200/Jco.2018.36.4_Suppl.293 |
0.356 |
|
| 2018 |
Mansfield AS, Peikert T, Smadbeck JB, Udell JB, Kosari F, Murphy SJ, Ren H, Serla VV, Klein JLS, Karagouga G, Harris FR, Sosa C, Johnson SH, Nevala W, Markovic SN, ... ... Vasmatzis G, et al. Abstract 5726: Rearrangement-related peptides with neoantigenic potential in malignant pleural mesothelioma Cancer Research. 78: 5726-5726. DOI: 10.1158/1538-7445.Am2018-5726 |
0.415 |
|
| 2018 |
Kovtun IV, Piyan Z, Harris FR, Hou X, Weroha SJ, Vasmatzis G. Abstract LB-A19: Targeting ERBB2 pathway in ovarian cancer Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-Lb-A19 |
0.349 |
|
| 2018 |
Aguirre JJ, Baughn L, Hoppman N, Vasmatzis G, Smadbeck J, Johnson S, Smoley S, Pitel B, Greipp P, Ketterling R, Peterson J. Use of Mate-Pair Sequencing (MPseq) to Elucidate a Complex BCR-ABL1 Rearrangement Observed in a Newly Diagnosed Case of Chronic Myeloid Leukemia American Journal of Clinical Pathology. 150. DOI: 10.1093/Ajcp/Aqy102.314 |
0.304 |
|
| 2018 |
Mendoza CJZ, Smoley SA, Johnson SH, Baughn LB, Greipp PT, Vasmatzis G, Hoppman NL, Ketterling RP. 14. Clinical mate-pair sequencing reveals complex genomic rearrangements in B-lymphoblastic leukemia/lymphoma (B-ALL) Cancer Genetics and Cytogenetics. 224: 55-56. DOI: 10.1016/J.Cancergen.2018.04.017 |
0.308 |
|
| 2018 |
Baughn LB, Smoley SA, Aypar U, Pitel BA, Vasmatzis G, Johnson SH, Smadbeck JB, Peterson JF, Geiersbach KB, Dyke DLV, Thorland EC, Ketterling RP, Jenkins RB, Hoppman NL, Kearney HM, et al. 13. Clinical utility of mate pair sequencing to detect diagnostic and prognostic chromosomal rearrangements and copy number changes in patients with acute myeloid leukemia Cancer Genetics and Cytogenetics. 36. DOI: 10.1016/J.Cancergen.2018.04.016 |
0.33 |
|
| 2018 |
Johnson SH, Smadbeck J, Harris F, Mansfield A, Gaitatzes A, Murphy S, Vasmatzis G. 9. Detection of fusion genes from complex rearrangements reported by genome-wide mate-pair sequencing (MPseq) Cancer Genetics and Cytogenetics. 53-54. DOI: 10.1016/J.Cancergen.2018.04.012 |
0.341 |
|
| 2017 |
Murphy SJ, Kosari F, Karnes RJ, Nasir A, Johnson SH, Gaitatzes AG, Smadbeck JB, Rangel LJ, Vasmatzis G, Cheville JC. Retention of Interstitial Genes between TMPRSS2 and ERG Is Associated with Low-Risk Prostate Cancer. Cancer Research. PMID 29127096 DOI: 10.1158/0008-5472.Can-17-0529 |
0.377 |
|
| 2017 |
Murphy SJ, Terra SB, Harris FR, Nasir A, Voss JS, Smadbeck JB, Johnson SH, Serla V, Ryu JH, Yi ES, Kipp BR, Vasmatzis G, Carmona EM. Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28643793 DOI: 10.1038/Modpathol.2017.52 |
0.356 |
|
| 2017 |
Catic A, Kurtovic-Kozaric A, Johnson SH, Vasmatzis G, Pins MR, Kogan J. A novel cytogenetic and molecular characterization of renal metanephric adenoma: Identification of partner genes involved in translocation t(9;15)(p24;q24). Cancer Genetics. 214: 9-15. PMID 28595733 DOI: 10.1016/J.Cancergen.2017.03.001 |
0.368 |
|
| 2017 |
Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28338654 DOI: 10.1038/Modpathol.2017.24 |
0.354 |
|
| 2017 |
Menke JR, Vasmatzis G, Murphy S, Yang L, Menke DM, Tun HW, King RL, Smoley SA, Ketterling RP, Sukov WR. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): A proposed alternative mechanism of CCND1 upregulation. Human Pathology. PMID 28132860 DOI: 10.1016/J.Humpath.2017.01.001 |
0.334 |
|
| 2017 |
Sosa CP, Sosa DN, Vasmatzis G. Toward the integration of mate pair and RNA sequencing to identify gene fusions in cancer research: a mini review Moj Proteomics & Bioinformatics. 5. DOI: 10.15406/Mojpb.2017.05.00175 |
0.309 |
|
| 2017 |
Harris FR, Yang L, Hou X, Leventakos K, Weroha SJ, Vasmatzis G, Kovtun IV. Abstract A34: Targeting genes which are amplified in ovarian cancer Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-A34 |
0.374 |
|
| 2016 |
Gao G, Johnson SH, Vasmatzis G, Pauley CE, Tombers NM, Kasperbauer JL, Smith DI. Common Fragile Sites and Extremely Large are Targets for Human Papillomavirus Integrations and Chromosome Rearrangements in Oropharyngeal Squamous Cell Carcinoma. Genes, Chromosomes & Cancer. PMID 27636103 DOI: 10.1002/Gcc.22415 |
0.34 |
|
| 2016 |
Harris FR, Kovtun IV, Smadbeck J, Multinu F, Jatoi A, Kosari F, Kalli KR, Murphy SJ, Halling GC, Johnson SH, Liu MC, Mariani A, Vasmatzis G. Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers. Scientific Reports. 6: 29831. PMID 27436510 DOI: 10.1038/Srep29831 |
0.367 |
|
| 2016 |
Jang JS, Wang X, Vedell PT, Wen J, Zhang J, Ellison DW, Evans JM, Johnson SH, Yang P, Sukov WR, Oliveira A, Vasmatzis G, Sun Z, Jen J, Yi ES. Custom Gene Capture and Next Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27343444 DOI: 10.1016/J.Jtho.2016.06.001 |
0.323 |
|
| 2016 |
Boddicker RL, Razidlo GL, Dasari S, Zeng Y, Hu G, Knudson RA, Greipp PT, Davila JI, Johnson SH, Porcher JC, Smadbeck JB, Eckloff BW, Billadeau DD, Kurtin PJ, McNiven MA, ... ... Vasmatzis G, et al. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma. Blood. PMID 27297792 DOI: 10.1182/Blood-2016-03-707141 |
0.371 |
|
| 2016 |
Gleeson FC, Kerr SE, Kipp BR, Voss JS, Minot DM, Tu ZJ, Henry MR, Vasmatzis G, Cheville JC, Lazaridis KN, Levy MJ. Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom 2-gene targeted next-generation sequencing panel with therapeutic intent. Gastrointestinal Endoscopy. PMID 27118626 DOI: 10.1016/J.Gie.2016.04.027 |
0.328 |
|
| 2016 |
Murphy S, Harris F, Karagouga G, Wigle D, Vasmatzis G, Aubry MC. Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Oa1781 |
0.363 |
|
| 2016 |
Harris FR, Halling GC, Becker MA, Haluska P, Vasmatzis G, Kovtun IV. Abstract 13: Individualized approach for ovarian cancer: Identification of potential therapeutic targets based on genomic analyses, testing efficiency of treatments, and monitoring Clinical Cancer Research. 22: 13-13. DOI: 10.1158/1557-3265.Pmsclingen15-13 |
0.391 |
|
| 2016 |
Leventakos K, Mansfield AS, Murphy SJ, Johnson SH, Kerr SE, Aubry MC, Vasmatzis G, Molina JR. Abstract 4513: A prognostic model for pulmonary carcinoid tumors based on large chromosomal alterations Cancer Research. 76: 4513-4513. DOI: 10.1158/1538-7445.Am2016-4513 |
0.387 |
|
| 2016 |
Harris FR, Kovtun I, Smadbeck J, Multinu F, Jatoi A, Kalli KR, Murphy SJ, Halling GC, Kosari F, Johnson SH, Mariani A, Vasmatzis G. Abstract 440: Quantification of somatic chromosomal rearrangements in circulating cell-free DNA from ovarian cancers Cancer Research. 76: 440-440. DOI: 10.1158/1538-7445.Am2016-440 |
0.308 |
|
| 2016 |
Bhinge KN, Lin Y, Rahi H, Aubry MC, Mansfield A, Kovtun I, Murphy S, Yang P, Wigle D, Yi J(, Nasir A, Terra S, Molina J, Vasmatzis G, Kosari F. Abstract 1129: EGFR-mediated activation of RET in ASCL1+ lung adenocarcinoma Cancer Research. 76: 1129-1129. DOI: 10.1158/1538-7445.Am2016-1129 |
0.317 |
|
| 2016 |
Gleeson F, Kipp BR, Voss J, Minot D, Tu Z, Kerr S, Henry M, Vasmatzis G, Cheville J, Lazaridis K, Levy MJ. Sa1521 SMAD4 Biomarker Stratification Strategy via Endoscopic Ultrasound Fine Needle Aspiration Using Targeted Next-Generation Sequencing for Patients With Pancreatic and Ampullary Adenocarcinoma Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)31164-7 |
0.301 |
|
| 2016 |
Mansfield A, Murphy S, Peikert T, Yi J, Vasmatzis G, Wigle D, Aubry MC. Heterogeneity of programmed cell death-ligand 1 expression in lung cancer Journal of Thoracic Oncology. 11. DOI: 10.1016/J.Jtho.2015.12.053 |
0.325 |
|
| 2016 |
Gleeson F, Kipp BR, Voss J, Minot D, Tu Z, Kerr S, Henry M, Cheville J, Lazaridis K, Levy MJ, Vasmatzis G. Su1277 Tumor Heterogeneity Assessment of EUS FNA Cytology to Matched Surgical Pathology via Targeted Next Generation Sequencing in a Pancreatic and Ampullary Adenocarcinoma Population Gastrointestinal Endoscopy. 83. DOI: 10.1016/J.Gie.2016.03.851 |
0.304 |
|
| 2016 |
Porath B, Johnson SH, Smoley SA, Pitel B, Gliem T, Vasmatzis G, Kearney HM, Hoppman NL, Thorland EC. Molecular Characterization of Recurrent Partial Gene Duplications by Whole Genome Mate-Pair Sequencing (MPseq) to Improve the Accuracy of Chromosomal Microarray Reporting Cancer Genetics. 209: 299-300. DOI: 10.1016/J.Cancergen.2016.04.051 |
0.357 |
|
| 2016 |
Marcou CA, Halling G, Johnson SH, Smoley S, Pearce K, Vasmatzis G, Thorland EC, Aypar U, Hoppman NL. What's Next in Cytogenetics: Molecular Characterization of De Novo Apparently Balanced Chromosomal Rearrangements to Assess Pathogenicity by Whole Genome Mate Pair Sequencing Cancer Genetics. 209: 298. DOI: 10.1016/J.Cancergen.2016.04.048 |
0.326 |
|
| 2016 |
Baughn L, Essendrup A, Smoley SA, Porath B, Johnson SH, Vasmatzis G, Jackson D, Kearney H. Characterization of a Novel Inverted Tandem Duplication by Mate Pair Sequencing (MPseq) Cancer Genetics. 209: 296-297. DOI: 10.1016/J.Cancergen.2016.04.042 |
0.312 |
|
| 2016 |
Smoley SA, Johnson SH, Vasmatzis G, Kearney HM, Ketterling RP, Jenkins RB. Whole-Genome Mate-Pair Sequencing (MPseq) Improves Genomic Characterization of Patients with Hematologic Malignancies Cancer Genetics. 209: 294-295. DOI: 10.1016/J.Cancergen.2016.04.036 |
0.319 |
|
| 2016 |
Johnson SH, Smoley SA, Kearney HM, Sukov WR, Jenkins RB, Vasmatzis G. A Comparison of Whole Genome Mate Pair Sequencing (MPseq) with Karyotype and FISH for Breakpoint Detection in Hematologic Cancers Cancer Genetics. 209: 290. DOI: 10.1016/J.Cancergen.2016.04.022 |
0.349 |
|
| 2015 |
Murphy SJ, Hart SN, Halling G, Johnson SH, Smadbeck JB, Drucker T, Felipe Lima J, Rakhshan Rohakhtar F, Harris FR, Kosari F, Subramanian S, Petersen GM, Wiltshire TD, Kipp BR, Truty MJ, ... ... Vasmatzis G, et al. Integrated genomic analysis of pancreatic ductal adenocarcinomas reveals genomic rearrangement events as significant drivers of disease. Cancer Research. PMID 26676757 DOI: 10.1158/0008-5472.Can-15-2198 |
0.371 |
|
| 2015 |
Murphy SJ, Karnes RJ, Kosari F, Castellar BE, Kipp BR, Johnson SH, Terra S, Harris FR, Halling GC, Klein JL, Nasir A, Bergstrahl E, Rangel LJ, Sukov WR, Vasmatzis G, et al. Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26612463 DOI: 10.1038/Modpathol.2015.136 |
0.365 |
|
| 2015 |
Schaefer-Klein JL, Murphy SJ, Johnson SH, Vasmatzis G, Kovtun IV. Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression. Plos One. 10: e0142327. PMID 26560244 DOI: 10.1371/Journal.Pone.0142327 |
0.347 |
|
| 2015 |
Kovtun IV, Murphy SJ, Johnson SH, Cheville JC, Vasmatzis G. Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer. Oncotarget. 6: 29087-96. PMID 26337081 DOI: 10.18632/Oncotarget.4900 |
0.374 |
|
| 2015 |
Cradic KW, Murphy SJ, Sikkink RA, Neuhauser C, Vasmatzis G, Grebe SK. Clinical validation of a haplotyping method with next-generation sequencing. Clinical Chemistry. 61: 430-1. PMID 25388428 DOI: 10.1373/Clinchem.2014.228627 |
0.322 |
|
| 2015 |
Lu J, Lonergan PE, Nacusi LP, Wang L, Schmidt LJ, Sun Z, Van der Steen T, Boorjian SA, Kosari F, Vasmatzis G, Klee GG, Balk SP, Huang H, Wang C, Tindall DJ. The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells. The Journal of Urology. 193: 690-8. PMID 25132238 DOI: 10.1016/J.Juro.2014.08.043 |
0.314 |
|
| 2014 |
Murphy SJ, Aubry MC, Harris FR, Halling GC, Johnson SH, Terra S, Drucker TM, Asiedu MK, Kipp BR, Yi ES, Peikert T, Yang P, Vasmatzis G, Wigle DA. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4050-8. PMID 25385739 DOI: 10.1200/Jco.2014.56.7644 |
0.353 |
|
| 2014 |
Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood. 124: 1473-80. PMID 24894770 DOI: 10.1182/Blood-2014-04-571091 |
0.317 |
|
| 2014 |
Murphy SJ, Wigle DA, Lima JF, Harris FR, Johnson SH, Halling G, Asiedu MK, Seto CT, Terra S, Kosari F, Peikert T, Yang P, Aubry MC, Vasmatzis G. Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma. Cancer Research. 74: 3157-67. PMID 24879567 DOI: 10.1158/0008-5472.Can-13-1727 |
0.337 |
|
| 2014 |
Graham RP, Barr Fritcher EG, Pestova E, Schulz J, Sitailo LA, Vasmatzis G, Murphy SJ, McWilliams RR, Hart SN, Halling KC, Roberts LR, Gores GJ, Couch FJ, Zhang L, Borad MJ, et al. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. Human Pathology. 45: 1630-8. PMID 24837095 DOI: 10.1016/J.Humpath.2014.03.014 |
0.351 |
|
| 2014 |
Ansell SM, Hodge LS, Secreto FJ, Manske M, Braggio E, Price-Troska T, Ziesmer S, Li Y, Johnson SH, Hart SN, Kocher JP, Vasmatzis G, Chanan-Kahn A, Gertz M, Fonseca R, et al. Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma. Blood Cancer Journal. 4: e183. PMID 24531446 DOI: 10.1038/Bcj.2014.4 |
0.338 |
|
| 2014 |
Drucker TM, Johnson SH, Murphy SJ, Cradic KW, Therneau TM, Vasmatzis G. BIMA V3: an aligner customized for mate pair library sequencing. Bioinformatics (Oxford, England). 30: 1627-9. PMID 24526710 DOI: 10.1093/Bioinformatics/Btu078 |
0.322 |
|
| 2014 |
Kosari F, Ida CM, Aubry MC, Yang L, Kovtun IV, Klein JL, Li Y, Erdogan S, Tomaszek SC, Murphy SJ, Bolette LC, Kolbert CP, Yang P, Wigle DA, Vasmatzis G. ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation. Oncogene. 33: 3776-83. PMID 24037524 DOI: 10.1038/Onc.2013.359 |
0.323 |
|
| 2014 |
Feldman AL, Vasmatzis G, Asmann YW, Johnson SH, Eckloff BW, Middha S, Davila JI, Kurtin PJ, Link BK, Ansell SM, Cerhan JR. Abstract 5585: Integrated DNA/RNA sequencing for discovery and orthogonal validation of expressed fusion genes in peripheral T-cell lymphomas Cancer Research. 74: 5585-5585. DOI: 10.1158/1538-7445.Am2014-5585 |
0.386 |
|
| 2014 |
Kosari F, Ida CM, Aubry MC, Yang L, Kovtun IV, Klein JLS, Tomaszek SC, Murphy SJ, Yang P, Wigle D, Vasmatzis G. Abstract 5251: ASCL1 and RET expression define a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation Cancer Research. 74: 5251-5251. DOI: 10.1158/1538-7445.Am2014-5251 |
0.329 |
|
| 2014 |
Vasmatzis G, Feldman AL, Johnson SH, Thorland EC, Fonseca R, Braggio E, Gliem TJ. Abstract 3572: Copy number detection using genomics technologies: A comparison between aCGH and NGS Cancer Research. 74: 3572-3572. DOI: 10.1158/1538-7445.Am2014-3572 |
0.353 |
|
| 2014 |
Gleeson FC, Kipp BR, Voss JS, Campion MB, Henry M, Sciallis AP, Graham R, Lazaridis K, Vasmatzis G, Levy MJ. Sa1911 EUS FNA Cytology Next-Generation Sequencing: the FBXW7 Gene Pathogenic Alteration Profile in Treatment Naive Locally Advanced Rectal Cancer Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)61180-X |
0.335 |
|
| 2014 |
Gleeson FC, Kipp BR, Voss JS, Campion MB, Henry M, Sciallis AP, Graham R, Lazaridis K, Vasmatzis G, Levy MJ. Mo1355 Prognostic Multigene Mutation Profile of EUS FNA Cytology Specimens by Next- Generation Sequencing in Locally Advanced Rectal Cancer Gastrointestinal Endoscopy. 79. DOI: 10.1016/J.Gie.2014.02.532 |
0.323 |
|
| 2013 |
Gomez CR, Kosari F, Munz JM, Schreiber CA, Knutson GJ, Ida CM, El Khattouti A, Karnes RJ, Cheville JC, Vasmatzis G, Vuk-Pavlović S. Prognostic value of discs large homolog 7 transcript levels in prostate cancer. Plos One. 8: e82833. PMID 24349376 DOI: 10.1371/Journal.Pone.0082833 |
0.348 |
|
| 2013 |
Feldman AL, Vasmatzis G, Asmann YW, Davila J, Middha S, Eckloff BW, Johnson SH, Porcher JC, Ansell SM, Caride A. Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma. Genes, Chromosomes & Cancer. 52: 1097-102. PMID 23999969 DOI: 10.1002/Gcc.22104 |
0.363 |
|
| 2013 |
Lasho T, Johnson SH, Smith DI, Crispino JD, Pardanani A, Vasmatzis G, Tefferi A. Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high resolution mate-pair sequencing. American Journal of Hematology. 88: 741-6. PMID 23733509 DOI: 10.1002/Ajh.23495 |
0.318 |
|
| 2013 |
Kovtun IV, Cheville JC, Murphy SJ, Johnson SH, Zarei S, Kosari F, Sukov WR, Karnes RJ, Vasmatzis G. Lineage relationship of Gleason patterns in Gleason score 7 prostate cancer. Cancer Research. 73: 3275-84. PMID 23695551 DOI: 10.1158/0008-5472.Can-12-2803 |
0.324 |
|
| 2013 |
Murphy SJ, Wigle DA, Harris FR, Lima JF, Johnson SH, Eckloff BW, Seto CT, Asiedu M, Peikert T, Yang P, Aubry M, Vasmatzis G. Genomic rearrangements in lung adenocarcinoma: Lineage relationships between the in situ and invasive components. Journal of Clinical Oncology. 31: 7568-7568. DOI: 10.1200/Jco.2013.31.15_Suppl.7568 |
0.305 |
|
| 2013 |
Ansell SM, Hodge LS, Secreto F, Manske M, Braggio E, Price-Troska T, Ziesmer S, Li Y, Johnson S, Hart S, Kocher J, Vasmatzis G, Chanan-Khan A, Gertz MA, Fonseca R, et al. Activation Of TAK1 By MYD88 L265P Drives Malignant B Cell Growth In Non-Hodgkin Lymphomas Blood. 122: 245-245. DOI: 10.1182/Blood.V122.21.245.245 |
0.327 |
|
| 2013 |
Ma T, Elkhattouti A, Kosari F, Karnes RJ, Cheville JC, Vasmatzis G, Vuk-Pavlović S, Gomez CR. Abstract 4056: Hypoxia as a tool for identifying prostate cancer-associated antigens. Cancer Research. 73: 4056-4056. DOI: 10.1158/1538-7445.Am2013-4056 |
0.317 |
|
| 2013 |
Castellar ERP, Vasmatzis G, Knudson RA, Ketterling RP, Grogg KL, Macon WR, Law ME, Ansell SM, Dogan A, Feldman AL. Abstract 3538: Genetic biomarkers for risk stratification of patients with peripheral T-cell lymphoma. Cancer Research. 73: 3538-3538. DOI: 10.1158/1538-7445.Am2013-3538 |
0.325 |
|
| 2012 |
Zhang Y, Foreman O, Wigle DA, Kosari F, Vasmatzis G, Salisbury JL, Van Deursen J, Galardy PJ. USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis Journal of Clinical Investigation. 122: 4362-4373. PMID 23187126 DOI: 10.1172/Jci63084 |
0.324 |
|
| 2012 |
Murphy SJ, Cheville JC, Zarei S, Johnson SH, Sikkink RA, Kosari F, Feldman AL, Eckloff BW, Karnes RJ, Vasmatzis G. Mate pair sequencing of whole-genome-amplified DNA following laser capture microdissection of prostate cancer. Dna Research : An International Journal For Rapid Publication of Reports On Genes and Genomes. 19: 395-406. PMID 22991452 DOI: 10.1093/Dnares/Dss021 |
0.381 |
|
| 2012 |
Vasmatzis G, Johnson SH, Knudson RA, Ketterling RP, Braggio E, Fonseca R, Viswanatha DS, Law ME, Kip NS, Ozsan N, Grebe SK, Frederick LA, Eckloff BW, Thompson EA, Kadin ME, et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood. 120: 2280-9. PMID 22855598 DOI: 10.1182/Blood-2012-03-419937 |
0.38 |
|
| 2012 |
Kosari F, Cheville JC, Ida CM, Karnes RJ, Leontovich AA, Sebo TJ, Erdogan S, Rodriguez E, Murphy SJ, Vasmatzis G. Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer. The American Journal of Pathology. 181: 34-42. PMID 22640805 DOI: 10.1016/J.Ajpath.2012.03.043 |
0.337 |
|
| 2012 |
Kosari F, Cheville JC, Ida CM, Karnes RJ, Leontovich AA, Sebo TJ, Erdogan S, Murphy SJ, Vasmatzis G. Abstract 3008: Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer Cancer Research. 72: 3008-3008. DOI: 10.1158/1538-7445.Am2012-3008 |
0.329 |
|
| 2012 |
Gomez CR, Munz JM, Kosari F, Karnes J, Cheville J, Ida C, Sebo T, Vasmatzis G, Vuk-Pavlovic S. Abstract 116: Targeting hypoxia for the identification of novel biomarkers for prostate cancer Cancer Research. 72: 116-116. DOI: 10.1158/1538-7445.Am2012-116 |
0.362 |
|
| 2011 |
Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, Porcher JC, Ozsan N, Wieben ED, Eckloff BW, Vasmatzis G. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood. 117: 915-9. PMID 21030553 DOI: 10.1182/Blood-2010-08-303305 |
0.353 |
|
| 2011 |
Gomez CR, Knutson GJ, Schreiber CA, Kosari F, Vasmatzis G, Vuk-Pavlovic S. Abstract LB-308: Hypoxia affects gene expression and proteome of prostate cancer cells Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-308 |
0.327 |
|
| 2010 |
Karnes RJ, Cheville JC, Ida CM, Sebo TJ, Nair AA, Tang H, Munz JM, Kosari F, Vasmatzis G. The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status. Cancer Research. 70: 8994-9002. PMID 21062978 DOI: 10.1158/0008-5472.Can-10-1358 |
0.311 |
|
| 2010 |
Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, ... ... Vasmatzis G, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. The Lancet. Oncology. 11: 321-30. PMID 20304703 DOI: 10.1016/S1470-2045(10)70042-5 |
0.303 |
|
| 2010 |
Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, Porcher JC, Özsan N, Wieben ED, Eckloff BW, Vasmatzis G. Massively Parallel Mate Pair DNA Library Sequencing for Translocation Discovery: Recurrent t(6;7)(p25.3;q32.3) Translocations In ALK-Negative Anaplastic Large Cell Lymphomas Blood. 116: 633-633. DOI: 10.1182/Blood.V116.21.633.633 |
0.362 |
|
| 2009 |
Boland JM, Erdogan S, Vasmatzis G, Yang P, Tillmans LS, Johnson MR, Wang X, Peterson LM, Halling KC, Oliveira AM, Aubry MC, Yi ES. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Human Pathology. 40: 1152-8. PMID 19386350 DOI: 10.1016/J.Humpath.2009.01.012 |
0.338 |
|
| 2009 |
Savci-Heijink CD, Kosari F, Aubry MC, Caron BL, Sun Z, Yang P, Vasmatzis G. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. American Journal of Pathology. 174: 1629-1637. PMID 19342368 DOI: 10.2353/Ajpath.2009.080778 |
0.319 |
|
| 2009 |
Leja J, Essaghir A, Essand M, Wester K, Öberg K, Tötterman TH, Lloyd R, Vasmatzis G, Demoulin JB, Giandomenico V. Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Modern Pathology. 22: 261-272. PMID 18953328 DOI: 10.1038/Modpathol.2008.174 |
0.327 |
|
| 2008 |
Kosari F, Munz JM, Savci-Heijink CD, Spiro C, Klee EW, Kube DM, Tillmans L, Slezak J, Karnes RJ, Cheville JC, Vasmatzis G. Identification of prognostic biomarkers for prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1734-43. PMID 18347174 DOI: 10.1158/1078-0432.Ccr-07-1494 |
0.312 |
|
| 2007 |
Vasmatzis G, Klee EW, Kube DM, Therneau TM, Kosari F. Quantitating tissue specificity of human genes to facilitate biomarker discovery. Bioinformatics (Oxford, England). 23: 1348-55. PMID 17384019 DOI: 10.1093/Bioinformatics/Btm102 |
0.311 |
|
| 2007 |
Kube DM, Savci-Heijink CD, Lamblin AF, Kosari F, Vasmatzis G, Cheville JC, Connelly DP, Klee GG. Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer. Bmc Molecular Biology. 8: 25. PMID 17376245 DOI: 10.1186/1471-2199-8-25 |
0.311 |
|
| 2006 |
Klee EW, Finlay JA, McDonald C, Attewell JR, Hebrink D, Dyer R, Love B, Vasmatzis G, Li TM, Beechem JM, Klee GG. Bioinformatics methods for prioritizing serum biomarker candidates. Clinical Chemistry. 52: 2162-4. PMID 18061989 DOI: 10.1373/Clinchem.2006.072868 |
0.307 |
|
| 2006 |
Parker AS, Kosari F, Lohse CM, Thompson RH, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer. 107: 37-45. PMID 16736510 DOI: 10.1002/Cncr.21952 |
0.332 |
|
| 2006 |
Murillo H, Schmidt LJ, Karter M, Hafner KA, Kondo Y, Ballman KV, Vasmatzis G, Jenkins RB, Tindall DJ. Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence. Genes, Chromosomes & Cancer. 45: 702-16. PMID 16615098 DOI: 10.1002/Gcc.20333 |
0.366 |
|
| 2005 |
Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clinical Cancer Research. 11: 5128-5139. PMID 16033827 DOI: 10.1158/1078-0432.Ccr-05-0073 |
0.342 |
|
| 2004 |
Sun Z, Yang P, Aubry MC, Kosari F, Endo C, Molina J, Vasmatzis G. Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung Molecular Cancer. 3: 35-35. PMID 15579197 DOI: 10.1186/1476-4598-3-35 |
0.342 |
|
| 2004 |
Yang P, Sun Z, Aubry MC, Kosari F, Bamlet W, Endo C, Molina JR, Vasmatzis G. Study design considerations in clinical outcome research of lung cancer using microarray analysis Lung Cancer. 46: 215-226. PMID 15474670 DOI: 10.1016/J.Lungcan.2004.03.012 |
0.359 |
|
| 2001 |
Yerushalmi N, Keppler-Hafkemeyer A, Vasmatzis G, Liu XF, Olsson P, Bera TK, Duray P, Lee B, Pastan I. ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues. Gene. 265: 55-60. PMID 11255007 DOI: 10.1016/S0378-1119(01)00347-X |
0.315 |
|
| 1999 |
Liu XF, Essand M, Vasmatzis G, Lee B, Pastan I. Identification of three new alternate human kallikrein 2 transcripts: evidence of long transcript and alternative splicing. Biochemical and Biophysical Research Communications. 264: 833-9. PMID 10544017 DOI: 10.1006/Bbrc.1999.1595 |
0.327 |
|
| 1999 |
Essand M, Vasmatzis G, Brinkmann U, Duray P, Lee B, Pastan I. High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate. Proceedings of the National Academy of Sciences of the United States of America. 96: 9287-92. PMID 10430935 DOI: 10.1073/Pnas.96.16.9287 |
0.315 |
|
| 1998 |
Brinkmann U, Vasmatzis G, Lee B, Yerushalmi N, Essand M, Pastan I. PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. Proceedings of the National Academy of Sciences of the United States of America. 95: 10757-62. PMID 9724777 DOI: 10.1073/Pnas.95.18.10757 |
0.361 |
|
| 1998 |
Vasmatzis G, Essand M, Brinkmann U, Lee B, Pastan I. Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis Proceedings of the National Academy of Sciences of the United States of America. 95: 300-304. PMID 9419370 DOI: 10.1073/Pnas.95.1.300 |
0.343 |
|
| 1997 |
Zhang C, Vasmatzis G, Cornette JL, DeLisi C. Determination of atomic desolvation energies from the structures of crystallized proteins Journal of Molecular Biology. 267: 707-726. PMID 9126848 DOI: 10.1006/Jmbi.1996.0859 |
0.525 |
|
| 1996 |
Vasmatzis G, Zhang C, Cornette JL, DeLisi C. Computational determination of side chain specificity for pockets in class I MHC molecules Molecular Immunology. 33: 1231-1239. PMID 9129159 DOI: 10.1016/S0161-5890(96)00090-9 |
0.541 |
|
| 1996 |
Vasmatzis G, Cornette J, Sezerman U, DeLisi C. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex. Journal of Molecular Biology. 261: 72-89. PMID 8760503 DOI: 10.1006/Jmbi.1996.0442 |
0.671 |
|
| 1994 |
Vasmatzis G, Brower R, Delisi C. Predicting immunoglobulin-like hypervariable loops Biopolymers - Peptide Science Section. 34: 1669-1680. PMID 7849228 DOI: 10.1002/Bip.360341211 |
0.507 |
|
| 1993 |
Brower RC, Vasmatzis G, Silverman M, Delisi C. Exhaustive conformational search and simulated annealing for models of lattice peptides Biopolymers. 33: 329-334. PMID 8461447 DOI: 10.1002/Bip.360330302 |
0.578 |
|
| Show low-probability matches. |